Allosteric modulation of protein oligomerization: an emerging approach to drug design.
about
Small Molecule Targeting of Protein-Protein Interactions through Allosteric Modulation of DynamicsBiochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia InfectionsCompounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization.Oligomeric interface modulation causes misregulation of purine 5´-nucleotidase in relapsed leukemia.Structural and functional analysis of RopB: a major virulence regulator in Streptococcus pyogenes.Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014).Synergistic Activity of Combined NS5A Inhibitors.Protein-Protein Interface and Disease: Perspective from Biomolecular Networks.The trimer interface in the quaternary structure of the bifunctional prokaryotic FAD synthetase from Corynebacterium ammoniagenes.Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.Complex Formation between Two Biosynthetic Enzymes Modifies the Allosteric Regulatory Properties of Both: AN EXAMPLE OF MOLECULAR SYMBIOSIS.Natural Conformational Sampling of Human TNFα Visualized by Double Electron-Electron Resonance.Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers.
P2860
Q26785992-DBD6D32C-42CD-4C65-8E3C-E16EE8508543Q28554573-C4D48985-AB2E-45B8-869D-CBD82B5289B4Q35643021-0931A698-D96B-4DAE-BA8C-CEB8E4B3DD93Q36166888-D5375903-EF46-4CE1-ADBA-4F5329480BB0Q36694367-63B7D485-9951-497B-B530-FD2F29F52E00Q38349917-C705E056-918D-4EDF-9390-2568AB146E36Q38741143-A0CD4624-F010-4433-9AB0-DABC766F6FB7Q38785911-DD2BE757-AC5A-4A5C-8205-61DAD50AE309Q38877270-828992B8-0F0C-44B5-AB11-342557A9750DQ38895022-78A475D3-3544-4366-87B0-C98B9CB1C0DCQ41077880-1A42738B-E6FB-4B35-9E45-28F65E0BBD66Q41823450-6E9A42F1-3B1A-4843-B2CE-0D5EF17F0F78Q48024823-20E3A8AF-B683-40D1-B543-0FF99CCC0433Q52651294-3CEB9541-C5DC-4677-8E89-D59D5EF008AD
P2860
Allosteric modulation of protein oligomerization: an emerging approach to drug design.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Allosteric modulation of protein oligomerization: an emerging approach to drug design.
@en
type
label
Allosteric modulation of protein oligomerization: an emerging approach to drug design.
@en
prefLabel
Allosteric modulation of protein oligomerization: an emerging approach to drug design.
@en
P2860
P356
P1476
Allosteric modulation of protein oligomerization: an emerging approach to drug design.
@en
P2093
Assaf Friedler
Ronen Gabizon
P2860
P356
10.3389/FCHEM.2014.00009
P577
2014-03-24T00:00:00Z